Earn Up To 17 CME/CE Credits
Bonus Presentation
Speaker: Adam Friedman, MD, FAAD
This presentation will explore a different approach in patient care with RHAPSIDO® (remibrutinib).
Speaker: Jenny Murase, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
Speakers: Tina Bhutani, MD, MAS and E. James Song, MD, FAAD
Speakers will discuss latest innovation in topical therapies.
Speaker: Omar Noor, MD
Join your colleagues for a peer discussion exploring the latest EBGLYSS data.
Speaker: Brent Moody, MD
Learn more about managing patients living with advanced CSCC. Join us for a discussion between Dr. Brent Moody, MD and a real advanced CSCC patient.
Speaker: Raja Sivamani, MD
Dr. Raja Sivamani will examine the unmet needs of patients with psoriasis who also have obesity or overweight, how each condition drives systemic inflammation, and practical strategies for integrating obesity management into psoriasis care.
Speaker: Nathalie Zeitouni, MD, FAAD
This program will provide an overview of the CSCC landscape, focusing on UNLOXCYT® (cosibelimab-ipdl), a checkpoint inhibitor for the treatment of locally advanced and metastatic CSCC that is not amenable to curative surgery or curative radiation.
Speaker: Raja Sivamani, MD
ICOTYDE is the first and only IL-23 receptor–targeted oral peptide in a once-daily pill for moderate to severe plaque psoriasis in adults and pediatric patients 12 years of age and older weighing at least 40 kg.
PROGRAM OBJECTIVES
1) Review unmet need in psoriasis
2) Introduce ICOTYDE mechanism of action
3) Discuss key safety and efficacy results from the ICONIC clinical trial program
Speaker: Adam Friedman, MD
Moderator: Adam Friedman, MD
Speakers: Brian Berman, MD, PhD, FAAD; Sarah S. Chisolm, MD, FAAD; David Cotter, MD, PhD; Jennifer Hsiao, MD
Tired of playing the guessing game with refractory hives? Join us for an interactive, case-based workshop on chronic spontaneous urticaria (CSU) management. We are diving straight into real-world clinical dilemmas and focusing on patient assessment and optimizing step-up care—from antihistamines to targeted biologics and pipeline therapies.
You will leave with actionable diagnostic and therapeutic strategies you can plug directly into your clinic schedule on Monday morning. Don’t miss out!
Moderator: David M. Miller, MD, PhD
Speakers: Sonia Cohen, MD, PhD; Anokhi Jambusaria, MD, MSCE; Soo Park, MD; Vishal A. Patel, MD
Join in for an interactive workshop on cutaneous squamous cell carcinoma (CSCC) management. This collaborative session offers a practical forum to discuss complex clinical scenarios, staging protocols, and therapeutic decision pathways alongside peer experts. Rather than relying on passive lectures, we will utilize facilitated small-group case analyses. This format provides an excellent opportunity to exchange diverse clinical perspectives, review current diagnostic criteria, and discuss the practical application of evolving treatment paradigms to your daily practice.
Disclaimer: Bonus Presentations are independently organized and not an official part of the Las Vegas Dermatology Seminar program. All presentations are Non-CME/CE unless otherwise noted.